IBDEI1DA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22790,1,3,0)
 ;;=3^Panmyelosis w/ Myelofibrosis,Acute,In Relapse
 ;;^UTILITY(U,$J,358.3,22790,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,22790,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,22791,0)
 ;;=D47.1^^104^1062^36
 ;;^UTILITY(U,$J,358.3,22791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22791,1,3,0)
 ;;=3^Myeloproliferative Disease,Chr
 ;;^UTILITY(U,$J,358.3,22791,1,4,0)
 ;;=4^D47.1
 ;;^UTILITY(U,$J,358.3,22791,2)
 ;;=^5002256
 ;;^UTILITY(U,$J,358.3,22792,0)
 ;;=D47.9^^104^1062^37
 ;;^UTILITY(U,$J,358.3,22792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22792,1,3,0)
 ;;=3^Neop Uncrt Behavior Lymphoid/Hematopoietic/Related Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,22792,1,4,0)
 ;;=4^D47.9
 ;;^UTILITY(U,$J,358.3,22792,2)
 ;;=^5002260
 ;;^UTILITY(U,$J,358.3,22793,0)
 ;;=C80.0^^104^1062^4
 ;;^UTILITY(U,$J,358.3,22793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22793,1,3,0)
 ;;=3^Disseminated Malig Neop,Unspec
 ;;^UTILITY(U,$J,358.3,22793,1,4,0)
 ;;=4^C80.0
 ;;^UTILITY(U,$J,358.3,22793,2)
 ;;=^5001388
 ;;^UTILITY(U,$J,358.3,22794,0)
 ;;=D47.2^^104^1062^28
 ;;^UTILITY(U,$J,358.3,22794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22794,1,3,0)
 ;;=3^Monoclonal Gammopathy
 ;;^UTILITY(U,$J,358.3,22794,1,4,0)
 ;;=4^D47.2
 ;;^UTILITY(U,$J,358.3,22794,2)
 ;;=^5002257
 ;;^UTILITY(U,$J,358.3,22795,0)
 ;;=C90.00^^104^1062^29
 ;;^UTILITY(U,$J,358.3,22795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22795,1,3,0)
 ;;=3^Multiple Myeloma,Not in Remission
 ;;^UTILITY(U,$J,358.3,22795,1,4,0)
 ;;=4^C90.00
 ;;^UTILITY(U,$J,358.3,22795,2)
 ;;=^5001752
 ;;^UTILITY(U,$J,358.3,22796,0)
 ;;=C84.00^^104^1062^31
 ;;^UTILITY(U,$J,358.3,22796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22796,1,3,0)
 ;;=3^Mycosis Fungoides,Unspec Site
 ;;^UTILITY(U,$J,358.3,22796,1,4,0)
 ;;=4^C84.00
 ;;^UTILITY(U,$J,358.3,22796,2)
 ;;=^5001621
 ;;^UTILITY(U,$J,358.3,22797,0)
 ;;=C84.09^^104^1062^30
 ;;^UTILITY(U,$J,358.3,22797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22797,1,3,0)
 ;;=3^Mycosis Fungoides,Extrnod & Solid Org Sites
 ;;^UTILITY(U,$J,358.3,22797,1,4,0)
 ;;=4^C84.09
 ;;^UTILITY(U,$J,358.3,22797,2)
 ;;=^5001630
 ;;^UTILITY(U,$J,358.3,22798,0)
 ;;=C79.71^^104^1063^2
 ;;^UTILITY(U,$J,358.3,22798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22798,1,3,0)
 ;;=3^Malig Neop Adrenal Gland,Right,Secondary
 ;;^UTILITY(U,$J,358.3,22798,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,22798,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,22799,0)
 ;;=C79.72^^104^1063^1
 ;;^UTILITY(U,$J,358.3,22799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22799,1,3,0)
 ;;=3^Malig Neop Adrenal Gland,Left,Secondary
 ;;^UTILITY(U,$J,358.3,22799,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,22799,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,22800,0)
 ;;=C79.51^^104^1063^5
 ;;^UTILITY(U,$J,358.3,22800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22800,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,22800,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,22800,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,22801,0)
 ;;=C79.52^^104^1063^4
 ;;^UTILITY(U,$J,358.3,22801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22801,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,22801,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,22801,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,22802,0)
 ;;=C79.31^^104^1063^6
 ;;^UTILITY(U,$J,358.3,22802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22802,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,22802,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,22802,2)
 ;;=^5001347
